Budenofalk (Budesonide)
245145USD

Budenofalk (Budesonide)

SKU:1999
To favorites
Budenofalk (Budesonide) has topical anti-inflammatory, anti-allergic, anti-exudative and decongestant properties
Active substance:Budesonide
Pharmacological group:Respiratory system
Country of origin:Germany
Brand:Budenofalk
In stock
$45
11
Description
Features
Reviews

Instructions for Budenofalk (Budesonide)

Dosage form
enteric granules 9 mg: packets of 20 g or 50 g

Description Budenofalk:

The granules are enteric-soluble in the form of a mixture of powder and rounded granules or rounded granules from white to almost white, with a lemon smell.
1 pack.
budesonide 9 mg

Excipients:

  • sugar grits - 900 mg,
  • lactose monohydrate - 36 mg,
  • povidone K25 - 2.7 mg.

Excipients (granule shell) Budenofalk:
methacrylic acid and methyl methacrylate copolymer 1:1
(Eudragite L 100) - 54.9 mg,
methacrylic acid and methyl methacrylate copolymer 1:2
(Eudragite S 100) - 54.9 mg,
methyl methacrylate,
trimethylammonioethyl methacrylate chloride and ethyl acrylate copolymer 2:0.1
(ammonio-methacrylate copolymer, type B, Eudragite RS) - 9 mg,
methyl methacrylate,
trimethylammonioethyl methacrylate chloride and ethyl acrylate copolymer 2:0.2:1
(ammonio-methacrylate copolymer,
type B, Eudragite RL) - 6.3 mg,
triethyl citrate - 12.6 mg,
talc - 134.1 mg.

English Product Name
Budenofalk

Dosage form
Caps. enteric 3 mg: 20, 50 or 100 pcs.

Description:

Enteric capsules hard gelatin, size No. 1, opaquent, white; the contents of the capsules are round pellets (granules) of white color.

1 caps.
budesonide 3 mg

Excipients:
granulated sugar - 300 mg,
lactose monohydrate - 12 mg,
povidone K25 - 0.9 mg,
copolymer of methacrylic acid and methyl methacrylate (1: 1) (eudragite L) - 18.3 mg,
copolymer of methacrylic acid and methyl methacrylate (1: 2) (eudragite S) - 18.3 mg,
copolymer of methyl methacrylate,
trimethylammonioethyl methacrylate chloride and ethyl acrylate [2: 0.1: 1]
(copolymer of ammoniomethacrylate (type B),
eudragite RS) - 3 mg,
copolymer of methyl methacrylate,
trimethylammonioethyl methacrylate chloride and ethyl acrylate [2: 0.2:1]
(ammoniomethacrylate copolymer (type A), eudragite RL) - 2.1 mg, triethyl citrate - 4.2 mg, talc - 44.7 mg.

ATX Codes
A07EA06 Budesonide

Clinical and pharmacological groups / Group affiliation
Corticosteroids for oral administration. The drug Budenofalk for the treatment of Crohn's disease

Active ingredient
budesonide

Pharmaco-therapeutic group
Glucocorticosteroid

Testimony Budenofalk:

For oral administration:
mild and moderate forms of Crohn's disease involving the ilium and / or ascending colon; collagenous (collagen) colitis; autoimmune hepatitis without histological signs of cirrhosis of the liver.

For rectal use:
exacerbation of distal forms of ulcerative colitis (with damage to the rectum and sigmoid colon).

Dosage, Course and Dosage:

When taken orally, the daily dose is six to nine mg. The frequency and duration of use depend on the treatment regimen.

Use in elderly patients
Use with caution in elderly patients to avoid exacerbation of chronic diseases.

Use in children
Contraindicated in children and adolescents under the age of 18 years.

  • Nosology (ICD codes)
  • K50
  • Crohn's disease [regional enteritis]
  • K51.2
  • Ulcerative (chronic) proctitis
  • K51.3
  • Ulcerative (chronic) rectosigmoiditis
  • K52.8
  • Other refined non-infectious gastroenteritis and colitis
  • K75.4
  • Autoimmune hepatitis

Pharmachologic effect:

GCS for system applications. The exact mechanism of action of budesonide in inflammatory bowel diseases is not fully understood. The data of clinical-pharmacological and controlled clinical studies clearly indicate that the mechanism of action of budesonide is mainly based on local action in the intestine.

When taken orally in doses clinically equal to those of systemic action, budesonide causes significantly less inhibition of the hypothalamic-pituitary-adrenal system and has less effect on markers of inflammation. When used rectally at a dose of two mg, budesonide practically does not cause inhibition of the hypothalamic-pituitary-adrenal system.

Features
Active substance
Pharmacological group
Country of origin
Brand
Expiration Date
No reviews yet — your comment may be first.
All reviews 0
general rating
Analogues
Pulmibud (Budesonide) ampoules
SKU:2047
$23
In stock
Pulmicort Turbuhaler (Budesonide) powder
SKU:2045
$27
In stock
Budesonide Easyhaler powder 200 doses
SKU:1998
$31
In stock